Phase 3 Study to Evaluate the Efficacy and Safety of ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Condition:   Pre-Bronchiolitis Obliterans Syndrome Interventions:   Drug: ARINA-1;   Other: Standard of care only Sponsor:   Renovion, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials

Study to Evaluate ARINA-1 in the Prevention of Bronchiolitis Obliterans Progression in Participants With Bilateral Lung Transplant
Condition:   Pre-Bronchiolitis Obliterans Syndrome Interventions:   Drug: ARINA-1;   Other: Standard of care only Sponsor:   Renovion, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 16, 2022 Category: Research Source Type: clinical trials